| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/05/2006 | US20060223088 Human secreted proteins |
| 10/05/2006 | US20060223082 Map |
| 10/05/2006 | US20060223063 Method of diagnosis of type 2 diabetes and early onset thereof |
| 10/05/2006 | US20060223055 Methods and compositions for treatment of viral lnfection |
| 10/05/2006 | US20060222654 Methods and compounds for raising antibodies and for screening antibody repertoires |
| 10/05/2006 | US20060222653 Antibodies operably linked to selected chemoattractants |
| 10/05/2006 | US20060222651 Staphylococcal immunotherapeutics via donor selection and donor stimulation |
| 10/05/2006 | US20060222650 Broad spectrum pyrogenic antagonists and vaccines directed against pyrogenic exotoxins |
| 10/05/2006 | US20060222649 Methods for inducing antigen-specific T cell tolerance |
| 10/05/2006 | US20060222648 Graft-versus-host disease; inhibit secretion of Interferon-gamma (IFN-?) by lymphocytes or other immune cells in a mammal; inflammatory bowel disease is Crohn's disease, ulcerative colitis, or ileitis; KIM-1 (Kidney Injury Molecule-1) |
| 10/05/2006 | US20060222646 Anti-TNFalpha antibodies in therapy of asthma |
| 10/05/2006 | US20060222645 Specifically bind to and neutralize angiopoietin-like protein 4 (ANGPTL4); disorder of lipid metabolism |
| 10/05/2006 | US20060222644 Humanized anti-Lymphotoxin beta receptor antibodies |
| 10/05/2006 | US20060222643 Anti-mpl antibody |
| 10/05/2006 | US20060222642 Compositions for the treatment of mycobacterial infections |
| 10/05/2006 | US20060222594 Smart magnetic nanosphere preparation and manufacturing method thereof |
| 10/05/2006 | US20060222588 Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
| 10/05/2006 | DE102005013846A1 Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie Identifying surface-associated antigens for tumor diagnosis and therapy |
| 10/05/2006 | CA2603692A1 Antibodies against ccr5 and uses thereof |
| 10/05/2006 | CA2603093A1 Antibodies and related molecules that bind to 161p2f10b proteins |
| 10/05/2006 | CA2602849A1 Doxorubicin immunoassay |
| 10/05/2006 | CA2602777A1 Gitr binding molecules and uses therefor |
| 10/05/2006 | CA2602663A1 Fc variants with optimized properties |
| 10/05/2006 | CA2602539A1 Monoclonal antibodies specific to denatured human class 1 leukocyte antigens |
| 10/05/2006 | CA2599988A1 Methods and compositions for modulating hyperstabilized c-met |
| 10/05/2006 | CA2598884A1 Influenza nucleic acids, polypeptides, and uses thereof |
| 10/04/2006 | EP1707628A1 Methods for producing recombinant polyclonal immunoglobulins |
| 10/04/2006 | EP1707627A1 Mutants of anti-cd40 antibody |
| 10/04/2006 | EP1707576A1 Antibodies recognizing methyllysine, process for producing the same and utilization thereof |
| 10/04/2006 | EP1707215A1 Remedy for angitis |
| 10/04/2006 | EP1707214A1 Antagonists of HMG1 for treating inflammatory conditions and the use of HMG1 for effecting weightloss or treating obesity |
| 10/04/2006 | EP1707051A2 Pluripotent cells having disrupted endogenous genes |
| 10/04/2006 | EP1706492A2 Materials and methods relating to cell cycle control |
| 10/04/2006 | EP1706481A2 Vaccine |
| 10/04/2006 | EP1706428A2 Anti-cancer antibodies with reduced complement fixation |
| 10/04/2006 | EP1706427A2 Human binding molecule against cd1a |
| 10/04/2006 | EP1706426A2 Nogoa antibodies for the treatment of alzheimer disease |
| 10/04/2006 | EP1706425A2 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse® |
| 10/04/2006 | EP1706424A1 Fc region variants |
| 10/04/2006 | EP1706423A2 Therapeutic and diagnostic anti-hsp 70 antibodies |
| 10/04/2006 | EP1706421A2 Methods of modulating cytokine activity; related reagents |
| 10/04/2006 | EP1706145A1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 10/04/2006 | EP1706144A2 Medicament comprising inhibitors of long pentraxin ptx3 |
| 10/04/2006 | EP1706143A1 Cd40 antibody formulation and methods |
| 10/04/2006 | EP1706079A2 Antibodies against factor viii with modified glycosylation in the variable region |
| 10/04/2006 | EP1664300A4 A new class of a2delta calcium channel subunits |
| 10/04/2006 | EP1558631A4 Methods and compositions for diagnosing and treating companion animal cancer |
| 10/04/2006 | EP1556508A4 Antibodies and methods for generating genetically altered antibodies with high affinity |
| 10/04/2006 | EP1311691B1 Method and compositions for promoting osteogenesis |
| 10/04/2006 | EP1247094A4 ASSAYS FOR DETECTION OF i BACILLUS ANTHRACIS /i |
| 10/04/2006 | EP1109918B1 Mitogen- and stress-activated protein kinases that contain two kinase domains and uses thereof |
| 10/04/2006 | EP1082435B1 Proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 10/04/2006 | EP1027375B1 Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions containing them |
| 10/04/2006 | EP1009832B1 Cytokine designated lerk-6 |
| 10/04/2006 | EP1003861B1 Mammalian cell membrane proteins; related reagents |
| 10/04/2006 | EP0783525B1 Humanized antibodies against respiratory syncytial virus |
| 10/04/2006 | CN1842541A Compositions and methods for regulating NK cell activity |
| 10/04/2006 | CN1842540A Anti-glypican 3 antibody |
| 10/04/2006 | CN1842539A Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
| 10/04/2006 | CN1842538A Modified binding molecules comprising connecting peptides |
| 10/04/2006 | CN1842346A Regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor |
| 10/04/2006 | CN1841106A Cam ring |
| 10/04/2006 | CN1841066A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 10/04/2006 | CN1840665A Virulence genes, proteins, and their use |
| 10/04/2006 | CN1840657A Monoclonal antibody against human chemotactic factor |
| 10/04/2006 | CN1840544A ESC42 protein, preparation method and use thereof |
| 10/04/2006 | CN1840178A Tumour-specific animal proteins |
| 10/04/2006 | CN1277844C Novel human cyclin, its coding sequence and application |
| 10/03/2006 | US7117096 Structure-based selection and affinity maturation of antibody library |
| 10/03/2006 | US7115729 Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 |
| 10/03/2006 | US7115725 Polypeptide for use in the generation of vaccine against diphtheria toxin |
| 10/03/2006 | US7115723 Humanized antibody specific for surface antigen pre-S1 of HBV and preparation method thereof |
| 10/03/2006 | US7115718 Haptens, immunogens, antibodies and conjugates to 2-oxo-3-hydroxy-LSD |
| 10/03/2006 | US7115717 Immunoglobulin specific to tumor necrosis factor -related apoptosis-inducing ligand (TRAIL) for use in the prevention and treatment of cancer; immnotherapy |
| 10/03/2006 | US7115716 Anticancer agents |
| 10/03/2006 | US7115715 Oncogenic protein for use in the diagnosis and treatment of tumors |
| 10/03/2006 | US7115713 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 10/03/2006 | US7115558 Anticancer, antitumor agents; brain disorders; skin disorders; polyclonal antibodies |
| 10/03/2006 | US7115557 Administering tumor necrosis factor inhibitors, interleukin -1, -6, or -8 inhibitors, FAS (ligand) gene/protein inhibitors or interferon gamma inhibitors; nerve disorder treatments |
| 10/03/2006 | US7115555 Amplification or reduction of hair follicle, tooth or sweat gland development; obtain tissue, incubate with modulator, monitor, tissue development |
| 10/03/2006 | US7115414 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders |
| 10/03/2006 | US7115404 UDP-galactose: β-D-galactose-R 4-α-D-galac-tosyltransferase, α4Gal-T1 |
| 10/03/2006 | US7115398 Nucleotide sequences coding polypeptide for use in the treatment of bone disorders |
| 10/03/2006 | US7115396 Protein scaffolds for antibody mimics and other binding proteins |
| 10/03/2006 | US7115395 DNAs encoding guinea pig histamine receptors of the H4 subtype |
| 10/03/2006 | US7115394 Isolated and/or recombinantly produced polypeptide; use in regulating spermatogenesis, cell differentiation and proliferation |
| 10/03/2006 | US7115392 Polynucleotides encoding human vascular endothelial growth factor 2 |
| 10/03/2006 | US7115390 Connective tissue growth factor fragments and methods and uses thereof |
| 10/03/2006 | US7115383 An amphetamine and a methamphetamine group linked by a linking group, a polyamino acid or a nonpolyamino acid label linked to a second linking group which is attached to first linking group at a equidistance from both drugs, and second linking group terminates in a functional group; antiboides; sample |
| 10/03/2006 | US7115382 contacting biological sample with an antibody having specific binding affinity for PAPP-A-, but not PAPP-A-/pro major basic protein complex, to detect PAPP-A- in the sample for screening for altered proliferation states in non-pregnant patients |
| 10/03/2006 | US7115379 A complex of an antibody or antigen-binding fragment and a polypeptide which chemoattracts peripheral blood monocytes or T-cells |
| 10/03/2006 | US7115378 Peptide biomarker and method of identification |
| 10/03/2006 | US7115371 Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders |
| 10/03/2006 | US7115271 Protein D—an IgD-binding protein of Haemophilus influenzae |
| 10/03/2006 | US7115268 Peptides derived from homologous sequences of the family of staphylococcal and streptococcal toxins, which may be polymeric, that provide protection against, or reduce the severity of toxic shock and septic shock from bacterial infections |
| 10/03/2006 | US7115264 Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections |
| 10/03/2006 | US7115263 Compositions and methods for treating hyperimmune response in the eye |
| 10/03/2006 | US7115261 Combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target. |
| 10/03/2006 | US7115260 Interleukin-1β converting enzyme like apoptotic protease-6 |
| 09/28/2006 | WO2006102200A2 Docetaxel immunoassay |